// App-Quantinova.ai

1435 : Anticoagulation Treatment with Low Molecular-Weight Heparin for Portal Vein Thrombosis in Liver Cirrhosis: Efficacy and Risk of Hemorrhagic Complications

Researchers

Presenter

  • Youngil Koh

Principal Investigators

  • Jung-Hwan Yoon

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Cirrhosis

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • dalteparin Subcutaneous

  • Enoxaparin

  • Enoxaparin sodium

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved